how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?
Author InfoJoanna Coast (Department of Social Medicine, University of Bristol, UK) Richard Smith (Health Economics Group, School of Health, Policy and Practice, University of East Anglia, UK) Anne-Marie Karcher (Department of Microbiology, Homerton Hospital, UK) Paula Wilton (Health Economics Group, School of Health, Policy and Practice, University of East Anglia, UK) Michael Millar (Barts and The London NHS Trust, UK) Abstract To date, there has been little examination of the problems associated with conducting economic evaluation for interventions designed to contain antimicrobial resistance. There are two quite different types of intervention aimed at containing antimicrobial resistance: interventions which are designed to avoid the emergence of resistant organisms; and interventions that are designed to avoid the transmission of resistance organisms. Four aspects of economic evaluation where the ease of assessment might be expected to differ across evaluations for these different t
